two decades, a trend that has been linked to changing 0.0001). Mean BMI in ORG was 41.7 (range 30.9 to 62.7).
dietary habits and sedentary lifestyle [1] [2] [3] . This inIndications for renal biopsy included proteinuria (N ϭ 40) creased prevalence has been reported in both children or proteinuria and renal insufficiency (N ϭ 31). Seventy-one and adults, and across diverse ethnic groups [1] . Acpatients with ORG were compared to 50 patients with idiopathic FSGS (I-FSGS). Patients with ORG were older (mean cording to the National Health and Nutrition Examina-42.9 vs. 32.6 years, P Ͻ 0.001) and more often Caucasian (75% tion Survey, the prevalence of obesity (defined as body vs. 52%; P ϭ 0.003). ORG patients had a lower incidence of mass index, BMI Ͼ30) has increased from 14.1% to nephrotic range proteinuria (48% vs. 66%; P ϭ 0.007) and 22 .5% between 1971 and 1994, and 54.9% of the U.S. nephrotic syndrome (5.6% vs. 54%; P Ͻ 0.001), with higher population is overweight (BMI Ͼ25) [1] . Obese patients serum albumin (3.9 vs. 2.9 g/dL; P Ͻ 0.001), lower serum cholesterol (229 vs. 335 mg/dL; P Ͻ 0.001), and less edema are at greater risk to develop sleep apnea, hyperlipid-(35% vs. 68%; P ϭ 0.003). On renal biopsy, patients with ORG emia, hypertension, coronary vascular disease, insulin had fewer lesions of segmental sclerosis (10 vs. 39%; P Ͻ resistance and diabetes [4] [5] [6] . 0.001), more glomerulomegaly (100% vs. 10%; P Ͻ 0.001), and
The renal effects of obesity in experimental animals less extensive foot process effacement (40 vs. 75%; P Ͻ 0.001). Glomerular diameter in ORG (mean 226 ) was significantly and humans include both structural and functional adaplarger than age-and sex-matched normal controls (mean 168 ; tations, such as increased glomerular filtration rate, in-P Ͻ 0.001). Follow-up was available in 56 ORG patients (mean creased renal blood flow, and renal hypertrophy [7, 8] .
27 months) and 50 idiopathic FSGS controls (mean 38 months).
In 1974, an association between massive obesity and A total of 75% of ORG patients received angiotensin-connephrotic-range proteinuria was first reported [9] . Since verting enzyme (ACE) inhibition or A2 blockade while 78% of the I-FSGS patients received immunosuppressive therapy.
that time, the development of glomerulomegaly and fo-ORG patients had less frequent doubling of serum creatinine cal segmental glomerulosclerosis (FSGS) has been linked (14.3% vs. 50%; P Ͻ 0.001) and progression to ESRD (3.6% to massive obesity [8, [10] [11] [12] [13] [14] . Most of these associations vs. 42%; P Ͻ 0.001). On multivariate analysis, presenting serum have been limited to case reports or small autopsy series.
creatinine and severity of proteinuria were the only predictors Thus, little is known about the overall prevalence of of poor outcome in ORG.
Conclusion. ORG is distinct from idiopathic FSGS, with a biopsy-documented obesity-related glomerulopathy, its lower incidence of nephrotic syndrome, more indolent course, presenting clinical features, morphologic manifestations, consistent presence of glomerulomegaly, and milder foot proor natural history. The current study was designed to determine the changing biopsy incidence of obesity-related glomeru-and pathologically distinct from I-FSGS. The differenti-(excluding cellular and collapsing variants) diagnosed ating clinicopathologic features of ORG have important from 1980 to 1992. implications for patient management and prognosis.
Renal biopsies for the study cohort and controls were processed for light microscopy, immunofluorescence (IF) and electron microscopy (EM) according to stan-METHODS dard techniques. At least 11 serial sections (3 m thick) All native renal biopsies accessioned in the Renal Pawere stained with hematoxylin and eosin, periodic-acid thology Laboratory of Columbia Presbyterian Medical Schiff (PAS), Masson's trichrome and Jones methenaCenter from January 1986 to April 2000 were reviewed mine-silver stains (JMS). Routine IF was performed on retrospectively for evidence of ORG. Obesity was de-3 m cryostat sections using polyclonal FITC-conjugated fined as a BMI Ͼ30, calculated as body weight in kiloantibodies to IgG, IgM, IgA, C3, C1q, , , fibrinogen grams divided by the square of height in meters [1, 15] .
and albumin (Dako Corporation, Carpenteria, CA, ORG was defined morphologically as (1) obesity-associ-USA). In 61 of 71 ORG cases, adequate glomerular ated FSGS with glomerulomegaly (O-FSGS) or (2) obetissue was available for EM. sity-associated glomerulomegaly alone (O-GM). Renal Juxtaglomerular apparatus (JGA) hyperplasia was debiopsies from obese patients with other underlying confined as Ͼ8 nuclei per cross section of JGA [18] . Tubular ditions that could cause secondary FSGS (such as HIV atrophy, interstitial fibrosis and inflammation were infection, heroin abuse, solitary kidney, congenital heart graded semiquantitatively on a scale of 0 to 3ϩ based disease, sickle cell disease, renal dysplasia, or any other on the % cortical area affected: 0 ϭ absent; 1ϩ ϭ 1-25%; pre-existing renal disease with loss of renal mass) were 2ϩ ϭ 26-50% and 3ϩ Ͼ 50%. Arteriosclerosis and artecarefully excluded. Moreover, other defined primary and riolosclerosis were graded as follows: 0 ϭ absent; 1ϩ ϭ secondary glomerular diseases including diabetic nemild; 2ϩ ϭ moderate; 3ϩ ϭ severe. The intensity of phropathy and hypertensive nephrosclerosis occurring staining by immunofluorescence was graded on a scale in obese patients were eliminated. Of all 6818 native of trace (ϩ/Ϫ) to 3ϩ. The percentage of foot process biopsies received during this period, a total of 103 cases effacement was estimated based on examination of all met the entry criteria. From this group, 71 cases with nonsclerotic glomerular capillaries in all fields. adequate clinical information were studied. Because of Measurement of glomerular diameter was performed the limited follow-up, newly diagnosed cases of obesityusing a light microscopic eyepiece with built-in microrelated glomerulopathy from the year 2000 were exmeter (Olympus Scientific, Tokyo, Japan). The convercluded.
sion factor for each objective was calibrated against a Patient charts were reviewed for age, sex, race, and standard by the manufacturer. Four levels of biopsy tispresenting clinical and laboratory features at the time sue (PAS and JMS stains) were studied in each case. All of renal biopsy. From the height and weight at the time glomeruli cut at or near the hilus were measured. Two of renal biopsy, BMI was calculated. Obesity was defined perpendicular diameters extending between the farthest as BMI Ͼ30 kg/m 2 : BMI 30.0 to 34.9 kg/m 2 , class I obesity; glomerular basement membrane points were measured BMI 35.0 to 39.9 kg/m 2 , class II obesity; BMI Ն40 kg/m 2 , per glomerulus. The mean glomerular diameter (m) class III or "morbid" obesity. The following definitions was calculated from a total of 5 to 30 (mean 15) glomeruli were used: hypertension (HTN), systolic pressure Ͼ140 examined per case. Glomerular diameter was compared mm Hg and diastolic pressure Ͼ90 mm Hg; nephrotic to that of 21 age-and sex-matched normal controls obrange proteinuria (NRP), 24-hour urine protein excretained from percutaneous renal biopsies of patients with tion Ն3.5 g; hematuria, presence of Ͼ5 red blood cells isolated asymptomatic hematuria or subnephrotic proper high power field on microscopic examination of the teinuria who had no evidence of glomerular disease by urinary sediment; hypoalbuminemia, serum albumin levlight microscopy, IF, or EM. els Յ3.5 g/dL; hypercholesterolemia, serum cholesterol
The following clinical and laboratory data at follow-Ͼ200 mg/dL; nephrotic syndrome, the combination of up were analyzed for the group with ORG and I-FSGS: NRP, hypoalbuminemia and edema; and renal insuffiTherapy directed to renal disease or obesity (including ciency, serum creatinine Ͼ1.2 mg/dL on two separate weight reduction, sleep apnea therapy, angiotensin-condeterminations. Creatinine clearances calculated from verting enzyme inhibitors (ACE-I) or angiotensin II re-24-hour urine collections were available in 58 patients.
ceptor antagonists, steroids or other immunosuppressive Clearances were adjusted for body surface area using agents) was recorded for each patient. . The male-to-female ratio was 44:27 (1.6). The majority of patients were Caucasian (75%), followed by African American (21%) and Hispanic (4%). Nine patients had history of diabetes mellitus (12.7%) for a mean duration of 4.8 years (range 0.5 to 26 years). However, none of these patients had renal biopsy findings of diabetic nephropathy. Forty-four patients had a prior history of hypertension of a mean 9 years' (range from 0.2 to 40 obstructive sleep apnea syndrome prior to renal biopsy; however, sleep apnea studies were not performed on the majority of patients.
The indications for renal biopsy were isolated proteinStatistical analysis uria in 40 patients (56%) and proteinuria and renal insufStatistical analysis was performed by exact statistical ficiency in 31 patients (44%). The mean serum creatinine inference using the following nonparametric methods:
at presentation was 1.5 mg/dL (range 0.6 to 6.3 mg/dL). Fisher's exact test, the Mann-Whitney U test, and the The creatinine clearance (C Cr ) was available in 58 paWilcoxon signed ranks test, as appropriate. The Monte tients and the mean value was 113 cc/min (range 20 to Carlo approximation method was used where the statisti-240 cc/min). The mean C Cr adjusted for BSA was 82.9 cal package could not solve the analysis by exact methodmL/min/1.73 m 2 (range 13 to 186). Twenty-four of 58 ology within 15 minutes or iteration processing time.
patients (41.4%) had C Cr Ͼ130 cc/min. Based on an ad-SPSS 10.0.5 was used to perform the analysis. Multivarijusted C Cr , 8 of 58 patients (13.8%) had a C Cr Ͼ130 mL/ ate analysis was performed by logistic regression analymin/1.73 m 2 and 32 patients (55%) had C Cr Ͻ75 mL/min/ sis. Patient and renal outcome survival analysis was per-1.73 m 2 . The mean 24-hour urine protein was 4.1 g (range formed by the method of Kaplan and Meier with 1 to 32 g). Although 34 patients (48%) had nephroticstatistical comparison by the log rank test. A multivariate range proteinuria at presentation, only 4 patients (5.6%) analysis for predictors of outcome was performed by had nephrotic syndrome. The mean serum albumin level Cox regression analysis. Statistical significance was aswas 3.9 g/dL (range 1.5 to 5.0 g/dL) and only ten patients sumed at P Ͻ 0.05.
(14%) had hypoalbuminemia. Twenty-five patients (35%) had pedal edema at presentation. The serum cholesterol levels ranged from 152 to 303 mg/dL (mean 229 RESULTS mg/dL) and 38 patients (54%) were hypercholesterolBiopsy incidence of obesity-related glomerulopathy emic. Microhematuria was documented in 15 patients. The biopsy incidence of ORG was determined for the When the presenting clinical features of the ORG 15-year period of January 1986 to April 2000 ( Fig. 1 ).
group were compared with I-FSGS controls, many sigAmong the 103 cases of ORG identified from 1986 to nificant differences were found (Table 1) . Patients with 2000, only two cases (2 of 956 native kidney biopsies;
ORG were more likely to be Caucasian (74.6 vs. 52%; 0.2%) were identified from January 1986 to December P ϭ 0.003) and tended to be older (mean age 42.9 vs. 1990; 24 cases (24 of 2013; 1.2%) were identified from 32.6 years; P Ͻ 0.001) compared to historical controls January 1991 to December 1995; and 77 cases (77 of with I-FSGS. Although nearly half of the ORG patients 3849; 2%) were identified from January 1996 to April presented with nephrotic-range proteinuria (48% vs. 2000. This represents a ten-fold increase in biopsy inci-66%; P ϭ 0.007), the incidence of pedal edema (35% dence of ORG over 15 years (P ϭ 0.0001).
vs. 68%; P ϭ 0.003) and nephrotic syndrome (5.6% vs. 60%; P Ͻ 0.001) was significantly lower in the ORG Clinical features at presentation group. Correspondingly, the mean serum albumin levels The mean age of patients at the time of biopsy diagnowere higher (3.9 g/dL vs. 2.9 g/dL; P Ͻ 0.001) and the sis of ORG was 42.9 years (range 8-71 years; Table 1 ).
mean 24-hour urine protein excretion was lower (4.1 g vs. 6.9 g; P ϭ 0.002) than in I-FSGS controls. The mean The youngest patients in the study group included an serum cholesterol level, although elevated, was signifiand the percentage of segmentally sclerotic glomeruli ranged from 3% to 50% (mean 12%; Table 1 ). All cases cantly lower than in I-FSGS patients (229 mg/dL vs. 335 mg/dL; P Ͻ 0.001). Although patients with ORG were had lesions of segmental sclerosis of the "classic" or usual type, characterized by segmental obliteration and more likely to be hypertensive (62% vs. 56%) and had slightly lower mean serum creatinine at biopsy (1.47 vs.
solidification of glomerular capillary lumina by increased matrix, forming expansile scars, often associated with 1.96 mg/dL), these differences were not statistically significant.
inframembranous hyaline, endocapillary foam cells and Bowman's capsular adhesions ( Fig. 2 A-C) . In some Because the ORG group contained some patients with glomerulomegaly alone (O-GM) as well as the larger cases, the hypertrophied podocytes overlying the lesions were segmentally detached from the glomerular basegroup with glomerulomegaly and FSGS (O-FSGS), comparative analyses were also performed for O-FSGS pament membranes and aligned over the sclerotic segment, forming a cellular "cap." In addition to these classic tients (N ϭ 57) versus I-FSGS controls (N ϭ 50). As shown in Table 1 , the differences were similar to those lesions, four cases also displayed focal cellular lesions of observed between the ORG and I-FSGS groups. Also, FSGS involving from 4 to 17% of glomeruli, one case within the study group of ORG, no statistically significant had a glomerular tip lesion, and a single case had one differences were found between those with O-FSGS and glomerulus with global collapse of the tuft and overlying O-GM with respect to any clinical parameter listed in prominent podocyte hyperplasia [19] [20] [21] . Of note, 2 of Table 1 (data not shown).
the 4 patients with full nephrotic syndrome had lesions of cellular or collapsing FSGS.
Renal biopsy findings
On analysis of the distribution of segmental lesions relative to the vascular pole, 11 O-FSGS cases (19%) Light microscopic findings. Among the 71 cases of ORG, 57 had lesions of FSGS with glomerulomegaly had exclusively perihilar lesions. In the remainder (81%), the lesions were in mixed perihilar and peripheral loca-(O-FSGS) and 14 cases had glomerulomegaly alone (O-GM). By light microscopy, the total number of glomeruli tions. Within the O-FSGS group, 16 cases (28%) also had one or more glomeruli with slightly increased matrix sampled ranged from 5 to 30 (mean 6.4 in O-GM; mean 14.2 in O-FSGS).
about the vascular pole, with or without associated hyalinosis; however, the size of these perihilar lesions did not In the O-FSGS group, the percentage of globally sclerotic glomeruli ranged from 0% to 73% (mean 25%) reach the threshold for diagnosis of segmental sclerosis. In O-FSGS, tubular atrophy and interstitial fibrosis was tients was the presence of focal "diabetoid" changes in the form of mild focal mesangial sclerosis or mild focal typically mild (mean 1.26ϩ), as was interstitial inflammation (mean 0.8ϩ). No tubular microcysts or significant thickening of glomerular basement membranes and tubular basement membranes (Fig. 2D) . One or more of tubular degenerative/regenerative changes were observed. The arteriolosclerosis (often with associated hyathese features were present in 32 (45%) cases. Six of these patients had history of non-insulin-dependent dialinosis) ranged from mild to moderate (mean 1.42ϩ).
In the O-GM group, by definition no lesions of global betes mellitus (NIDDM) and one had documented glucose intolerance. However, because these seven cases or segmental glomerulosclerosis were identified. However, three cases (21%) had slightly accentuated matrix had exclusively glomerular basement membrane thickening, without mesangial sclerosis, they did not meet about the vascular pole, as noted in some cases of O-FSGS. The tubular atrophy and interstitial fibrosis in diagnostic criteria for diabetic nephropathy. Juxtaglomerular apparatus (JGA) hyperplasia was this group were minimal (mean 0.36ϩ; range 0 to 1ϩ) and significantly less than in O-FSGS (P Ͻ 0.001). The seen in 14 (19.7%) of ORG cases, of which only 5 patients had a history of hypertension (of Ͻ2 years' duration in degree of arteriosclerosis (mean 1.0ϩ) was not significantly different from that of the O-FSGS group four cases and of 10 years' duration in one case). Interstitial foam cells were seen in 7 (10%) cases, 5 of whom (P ϭ 0.1).
Another histologic feature noted in some ORG pahad nephrotic range proteinuria. Immunofluorescence findings. In O-FSGS, there was to the mesangial positivity for IgM observed by immunofluorescence. In 25 cases of O-FSGS and 9 cases of focal and segmental or global staining of the glomerular tuft with antisera to IgM and C3 (1 to 2ϩ), corresponding O-GM, the glomerular basement membranes were mildly focally thickened (Fig. 2E) . Overlying patent capto areas of glomerulosclerosis. More generalized mesangial staining for IgM (1ϩ) was also common. Fifteen illaries, the podocytes had preserved primary processes with little if any microvillous transformation and with ORG cases had trace to 1ϩ linear staining of glomerular basement membranes with antisera to IgG and albumin, variable, but generally modest, foot process fusion (mean 40%, range 10 to 100%; Fig. 2F ). 4 of whom also had similar staining in the tubular basement membranes. Four of these 15 patients were diabetic Glomerular diameter. Mean glomerular diameter of ORG patients was 226 Ϯ 24.6 m (range 172 to 300 (1.5 to 26 years' duration) and one had documented glucose intolerance. m), a value significantly greater than that of age-and sex-matched normal controls (mean 168 Ϯ 12 m; range Electron microscopic findings. Lesions of segmental glomerulosclerosis demonstrated segmental solidifica-138 to 186 m; P Ͻ 0.001; Fig. 2 G, H) . The individual values are plotted in Figure 3 . tion of the tuft by basement membrane material and inframembranous hyaline. Overlying these areas, there
Comparative morphologic findings. On statistical analysis, the O-FSGS group had significantly fewer lewas frequent podocyte detachment and capping, with intervening layering of neomembrane material. Mild posions of segmental sclerosis than controls with I-FSGS (12% vs. 39%; P Ͻ 0.001). The percentage of globally docyte hypertrophy and intracytoplasmic protein resorption droplets were identified in a few cases. Few small sclerotic glomeruli was significantly higher in O-FSGS (but not ORG) than in I-FSGS (25% vs. 18%; P ϭ electron dense deposits were confined to the mesangial and paramesangial areas in 12 patients, corresponding 0.027). The incidence of glomerulomegaly, a defining FSGS (ORG vs. I-FSGS) was not predictive of hypercholesterolemia.
Therapy and clinical outcome
Of the 71 ORG patients, 15 patients (including 9 O-FSGS and 6 O-GM) were lost to follow-up (Table 2) . Thirty-four of the remaining 56 (61%) patients were treated with either ACE-I or angiotensin II receptor antagonists. Four additional patients (7%) were treated with both ACE-I and steroids, one of whom presented with nephrotic syndrome and had features of cellular FSGS on biopsy. Treatment was not statistically different between the O-FSGS and O-GM groups.
Follow-up was available on all 50 I-FSGS patients: 39 patients (78%) received immunosuppressive therapy, of The mean follow-up was 27 months (range 2 to 117 months) for the ORG group and 39 months (range 1 to 140 months) for the I-FSGS controls (P ϭ 0.049). Eight feature of ORG, was significantly higher in ORG versus patients with ORG (14.3%) had doubling of serum creat-I-FSGS (100% vs. 10%; P Ͻ 0.001). Patients with ORG inine and two of these patients (3.6%) progressed to tended to have more severe arteriolosclerosis compared ESRD requiring renal replacement therapy. By contrast, to I-FSGS (1.34ϩ vs. 0.98ϩ; P ϭ 0.03). However, the in the I-FSGS controls, 25 (50%) had doubling of serum severity of tubular atrophy and interstitial fibrosis was creatinine on follow-up, of whom 21 patients (42%) renot statistically different. There was significantly less foot quired renal replacement therapy (P Ͻ 0.001). The mean process effacement in ORG (mean 40%, range 10 to time to reach this end point was longer for ORG patients 100%) than in I-FSGS (mean 75%, range 30 to 100%; compared to I-FSGS patients (93 vs. 63 months; P ϭ P Ͻ 0.001).
0.023; Fig. 4 ). Among the 8 ORG patients who reached doubling of serum creatinine, all belonged to the Comparative multivariate analysis between ORG O-FSGS subgroup, 2 presented with nephrotic synand I-FSGS drome, and 1 had collapsing features on biopsy. Four of The parameters found to be significantly different by these 8 patients had been treated with ACE-I alone and univariate analysis between the groups (Table 1) were 4 received no therapy. There was no significant differanalyzed by multivariate analysis using logistic regresence in renal functional outcome of treated and unsion. When ORG was compared to I-FSGS, the only treated patients, as well as those treated with ACE-I parameters that were independently significant were sealone versus a combination of ACE-I and steroids. When rum albumin (P Ͻ 0.001) and age (P ϭ 0.032). When patients were dichotomized for BMI less than or greater the O-FSGS and I-FSGS groups were compared, again, than 40, no differences in outcome were identified. serum albumin (P Ͻ 0.001) and age (P ϭ 0.018) were Follow-up data on proteinuria was available in 26 pathe only independently significant variables. These retients with ORG, of whom 18 were receiving ACE-I. sults are consistent with the observation that the major Eighteen patients (69.2%) had a decline in 24-hour urine distinguishing feature between ORG and I-FSGS is the protein. Among these 26 patients, the mean 24-hour presence of full nephrotic syndrome in I-FSGS, as reurine protein declined from 3.92 to 2.55 g/day (P ϭ flected by the severity of hypoalbuminemia. 0.011). A mean reduction in urine protein excretion of By logistic regression analysis, both the type of FSGS 1.0 g/day was found in the 18 patients treated with ACE-I. (ORG vs. I-FSGS) and the 24-hour urinary protein exOf the 4 patients receiving steroid therapy, 3 had followcretion were significant and independent predictors of up data on proteinuria and 2 had an improvement in hypoalbuminemia (P ϭ 0.002 for the type of FSGS, with urine protein excretion (one with reduction in urine pro-I-FSGS being the stronger predictor of hypoalbumintein excretion from 13.0 to 1.4 g/day at 6 months of emia and P Ͻ 0.001 for 24-hour urine protein excretion.
follow-up and the other with reduction from 2.0 to 0.6 The 24-hour urine protein and serum albumin were both g/day at 98 months, both with stable renal function). significant and independent predictors of hypercholesterolemia (cholesterol Ͼ300 mg/dL), but the type of However, because so few patients were treated with ste- roids, any potential effect could not be analyzed statistifollowing: weight, BMI, duration of hypertension, prescally.
ence of diabetes, hematuria, follow-up time, ACE-I Five patients had significant weight loss ranging from treatment, steroid treatment, histologic subtype of seg-10% to 36% of their original weight over the 19 to 35 mental lesion (classic, cellular, collapsing), location of months of available follow-up. Four of these patients did segmental lesion (perihilar vs. peripheral), and glomerunot receive any other specific therapy. In all four cases, lar diameter. Only two factors were found to be preproteinuria declined by at least 50% and, in one case by dictive of poor outcome in the ORG group: presenting 75%. The renal function remained normal or stable in serum creatinine (P ϭ 0.003) and severity of proteinuria all four.
at presentation (P ϭ 0.022). Two patients with ORG died within 6 months of renal biopsy despite stable renal function. Causes of death DISCUSSION were congestive heart failure in a 54-year-old male and
The prevalence of obesity is on the rise in United sleep apnea in an 8-year-old girl.
States and in other industrialized nations and has Multivariate survival analysis was performed in ORG reached epidemic proportions [1] [2] [3] . Our findings of a using all the demographic, clinical, laboratory, and pathologic parameters listed in Table 1 as well as the tenfold increase in the biopsy incidence of this condition over the past 15 years are congruent with epidemiologic Kassiske, and likely reflect fundamental differences in the pathophysiology of this secondary form of FSGS [12, data documenting a sharply increasing prevalence of obesity in the general population. Because the indica-24, 25]. The reason why patients with ORG have a lower incidence of nephrotic syndrome compared to I-FSGS tions for renal biopsy (nephrotic range proteinuria, with or without renal insufficiency) have not changed apprecimay relate to differences in the severity of podocyte injury, in the severity and selectivity of proteinuria, and ably over this time period, we interpret our increasing biopsy incidence of ORG to reflect the increase in the in the ability of the tubules to reabsorb and catabolize the filtered protein. The lower fractional excretions of ␤ 2 -incidence of obesity. Previous reports of ORG have been in patients with massive obesity [8, 10-14]. Our study microglobulin (which competes with albumin for tubular uptake) and N-acetyl ␤-glucosaminidase (a marker of reveals, to our knowledge for the first time, that even patients with submorbid (class I and II) obesity, who tubular injury) observed in patients with nephrotic range proteinuria compared to those with nephrotic syndrome constituted 46% of the study group, can develop ORG that is clinically and morphologically indistinguishable suggest differences in tubular overload and resulting cellular injury. The urinary losses of protein in ORG may from that seen in morbid obesity.
Our study found a significantly higher incidence of be insufficient to stimulate the hepatic synthesis of lipoprotein typically observed in I-FSGS [24, 25] . Life table ORG in Caucasians compared to our biopsy population with I-FSGS (P ϭ 0.03). We can only speculate about analysis indicates that the course of ORG is indolent with less frequent progression to ESRD. Although our the reasons underlying these racial differences. These data may reflect genetically determined risk factors for historical controls with I-FSGS had significantly longer follow-up, life table analysis corrects for these differ-ORG as well as socioeconomic determinants that influence the rate of referral of obese patients of different ences. The favorable prognosis of ORG despite a lack of treatment with steroids in all but four patients provides races to a nephrologist.
The overall renal effects of obesity include elevated further proof that ORG is a distinct and separable clinicopathologic entity. GFR, elevated renal blood flow, and renal hypertrophy. The association of proteinuria with massive obesity was Although both ORG and I-FSGS manifest lesions of focal segmental glomerulosclerosis, there are distinfirst reported in 1974 [9] . The prevalence of proteinuria in obese patients has been addressed in several crossguishing morphologic features. As a group, ORG has a lower percentage of glomeruli affected by segmental sectional studies of large populations of obese patients. Among 257 obese patients screened at Brigham and sclerosis, suggesting a milder and more slowly progressive disease. Although routine histologic sections are Women's Hospital, only 4 (0.015%) had dipstick proteinuria of 2ϩ or greater, a value much lower than the prevaknown to underestimate the total number of glomeruli affected by focal segmental sclerosis, these differences lence of diabetes (15%) and hypertension (23%) in the same population (abstract; Goldszer et al, Kidney Int were obtained by examination of standardized numbers of tissue sections in the two groups [26] . Ultrastructur-25:165A, 1984). However, in another study of 207 nondiabetic obese patients, 25 (12%) had documented mially, the degree of foot process effacement was also less severe (mean 40% vs. 75%, P Ͻ 0.001), suggesting a croalbuminuria [22] . In the 1980's several case reports and small autopsy series of ORG appeared [8, 11, 13] . different pathomechanism of podocyte injury. However, because the range of % foot process fusion in each group Our study provides the first large comparative biopsy series on this entity.
was wide (10 to 100% for ORG and 30 to 100% for I-FSGS), the percentage of foot process fusion cannot Our data indicate that the presentation of ORG is typically one of nephrotic range-proteinuria (48%) or differentiate ORG from I-FSGS with certainty. Glomerulomegaly was consistently observed in ORG (100%) sub-nephrotic proteinuria (52%), accompanied by renal insufficiency in nearly half (44%). Although nearly half compared to only 10% of patients with I-FSGS, underscoring the importance of hyperfiltration mechanisms in of patients had nephrotic range proteinuria, hypoalbuminemia was present in only 14% and only 5.6% of its pathogenesis. These differences in the incidence of glomerulomegaly cannot be explained by loss of renal patients had full nephrotic syndrome. This presentation stands in sharp contrast to controls with I-FSGS, of mass as a stimulus to hyperfiltration, because the degree of glomerulosclerosis and chronic tubulointerstitial diswhom 54% had nephrotic syndrome (a value similar to the 70% rate of nephrotic syndrome estimated by Korbet ease, as well as the presenting serum creatinine levels, were higher in the I-FSGS group. Patients with ORG in a compilation of series of adult I-FSGS) [23] . Although 54% of ORG patients had hypercholesterolemia, correalso tended to have more severe arteriosclerosis (P ϭ 0.03), despite a similar incidence of hypertension as lating with the increased prevalence of hyperlipidemia in obesity, the mean serum cholesterol (229 mg/dL) was I-FSGS. These differences may be related to the older age and greater risk of coronary vascular disease in ORG. significantly lower than that in I-FSGS (335 mg/dL; P Ͻ 0.001). These results are similar to those of Praga and Of interest, only 5 (7.0%) cases of ORG had cellular or collapsing lesions. Although our study design precluded thickening). These findings correlate with the observation that "occult" diabetic nephropathy is common in comparisons with I-FSGS because our control group was restricted to cases with classic FSGS, this value is far obesity [12] and may reflect the higher prevalence of glucose intolerance, hyperinsulinemia, and hyperlipidlower than the 34% incidence of cellular lesions in I-FSGS described by Schwartz and Lewis [20] . ORG emia in the obese population. The pathophysiology of obesity-induced glomerulocases had little podocyte hypertrophy or hyperplasia, similar to the findings reported by Verani in an autopsy megaly and glomerular sclerosis is incompletely understood. Recent physiologic studies indicate that obese paseries of 22 obese patients [14] . The ability to determine the location of the sclerotic lesions within the threetients have elevations of both renal plasma flow and glomerular filtration rate (GFR) that exceed those of dimensional topography of the tuft in routine histologic sections is limited; nonetheless, our findings that 19% of controls by 31% and 51%, respectively, leading to increased filtration fraction [7] . They postulate a role for cases had exclusively perihilar sclerosis and 28% had accentuated matrix about the vascular pole are in agreeafferent arteriolar dilation in the mediation of the increased transcapillary hydraulic pressure gradient. Element with the predilection to perihilar sclerosis reported by Verani in ORG kidneys [14] . This tendency for sclerovation in GFR may be mediated in part by increased protein consumption. Because insulin directly reduces sis to involve the vascular pole may be related to the higher filtration pressure of the proximal glomerular capnorepinephrine-induced efferent arteriolar constriction, insulin resistance could have the effect of increasing the illary network due to its lower oncotic pressure. The limited tissue sampling in percutaneous renal biopsies transcapillary pressure gradient by increasing efferent arteriolar resistance [28] . Hyperinsulinemia has been did not permit evaluation of the distribution of segmental lesions with respect to the corticomedullary junction.
shown to stimulate the synthesis of growth factors such as insulin-like growth factor (IGF)-1 and IGF-2, which However, an autopsy series has shown that, unlike I-FSGS, there is no predilection for the corticomedullary may promote glomerular hypertrophy [29] . Elevated plasma levels of leptin in obesity [6] may predispose to junction in O-FSGS [14] .
Importantly, our series is the first, to our knowledge, glomerulosclerosis through up-regulation of transforming growth factor-␤ 1 (TGF-␤ 1 ) [30] . Hyperlipidemia to report that ORG may manifest with glomerulomegaly alone, in the absence of FSGS. The single report of itself also may promote glomerulosclerosis through mechanisms that involve engagement of low-density limassive obesity and nephrotic proteinuria with "normal renal biopsy" likely represents an unrecognized example poproteins (LDL) receptors on mesangial cells, oxidative cellular injury, macrophage chemotaxis, and increased of this entity [27] . It is possible that some of the cases of isolated glomerulomegaly represent unsampled O-FSGS production of fibrogenic cytokines [31] . Recent evidence suggests that hyperlipidemia may also mediate FSGS by because the mean number of glomeruli sampled in biopsies with O-GM was 6.4 (vs. 14.2 in O-FSGS). Nonethea direct podocyte toxicity [32] . The combination of focal segmental glomeruloscleroless, the occurrence of O-GM in nearly 20% of our study group, despite an ample glomerular sampling in many sis and glomerulomegaly in ORG resembles the secondary forms of focal segmental glomerulosclerosis arising cases, suggests that obesity-induced proteinuria results from adaptive structural-functional alterations causing in conditions of chronic hypoxia and altered glomerular capillary hemodynamics, such as cyanotic congenital glomerular hypertrophy and may not require the development of FSGS. Although it is possible that some of heart disease, sickle cell nephropathy, polycythemia and idiopathic pulmonary hypertension [33] [34] [35] . In all these these cases will evolve into FSGS, no patient in this group developed renal insufficiency in the follow-up peconditions, FSGS develops despite an initially normal nephron number. Similarly, hypoxia, hypercapnia and riod. The importance of glomerulomegaly and renal hypertrophy in the pathophysiology of obesity-associated systemic venous hypertension have been reported in obesity-induced sleep apnea [36, 37] . Even disordered proteinuria is underscored by the higher kidney weights observed at autopsy in obese patients compared to nonsleep breathing, in the absence of overt sleep apnea, can cause hypoxia-mediated activation of sympathetic obese controls [8] .
In addition to focal segmental glomerulosclerosis and nervous system, as evidenced by microneurographic studies and catecholomine levels [38, 39] . Sleep apnea glomerulomegaly, 45% of ORG biopsies had focal glomerular basement membrane thickening or focal mesanmay cause dysregulation of glomerular capillary hemodynamics directly through sympathetic control of effergial sclerosis reminiscent of the changes seen in early diabetic nephropathy (Fig. 2 D, E) . Although seven of ent arteriolar tone and indirectly through sympathetic activation of the renin-angiotensin system (RAS). There these patients were known to have NIDDM or glucose intolerance, they did not meet morphologic criteria for is some evidence that hyperinsulinemia itself can also activate the RAS [40, 41] . Finally, data from experimena diagnosis of diabetic nephropathy (that is, both diffuse mesangial sclerosis and glomerular basement membrane tal animals suggest that obesity promotes increased ma-
